Spiro Rombotis

Spiro Rombotis

Chief Executive Officer at CYCLACEL PHARMACEUTICALS, INC.

Net worth: 144 868 $ as of 2024-03-30

65 year
Health Technology
Consumer Services
Commercial Services

Network origin in Spiro Rombotis first degree

EntityEntity typeIndustry
Public Company Pharmaceuticals: Major 28
25
Private Company Miscellaneous Commercial Services 25
9
Extinct Pharmaceuticals: Major 9

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Spiro Rombotis via their personal network

CompanySectorRelated peopleMain position
BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Samuel Barker

Scott T. Megaffin

Corporate Officer/Principal

Corporate Officer/Principal

CELGENE Biotechnology

Sol Barer

Michele Korfin

Chief Executive Officer

Corporate Officer/Principal

Biotechnology

Dan Spiegelman

Jeffrey Nau

Treasurer

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Anthony Marucci

Annarie Lyles

Treasurer

Corporate Officer/Principal

Pharmaceuticals: Other

Christopher Henney

Kenneth Ferguson

Founder

President

ARQULE, INC. Pharmaceuticals: Major

Brian Schwartz

Mark Kirschbaum

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Biotechnology

Robert Nelsen

Scott T. Megaffin

Director/Board Member

Sales & Marketing

OMEROS CORPORATION Pharmaceuticals: Major

Dan Spiegelman

Kenneth Ferguson

Director/Board Member

Corporate Officer/Principal

PTC THERAPEUTICS, INC. Pharmaceuticals: Major

Stuart Peltz

Robert Spiegel

Founder

Chief Tech/Sci/R&D Officer

ANTHERA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Christopher Henney

Dan Spiegelman

Chairman

Director/Board Member

AEGERION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Sol Barer

Will Lewis

Director/Board Member

Founder

Miscellaneous Commercial Services

David C. U'Prichard

Stuart Peltz

Annarie Lyles

Emer Leahy

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Director/Board Member

NEXIMMUNE, INC. Pharmaceuticals: Major

Sol Barer

Robert Spiegel

Chairman

Chairman

INTENSITY THERAPEUTICS, INC. Biotechnology

Brian Schwartz

Emer Leahy

Chief Tech/Sci/R&D Officer

Director/Board Member

Pharmaceuticals: Major

Robert Westwood

Pierre Legault

Chief Tech/Sci/R&D Officer

Director of Finance/CFO

The Trustees of Columbia University in The City of New York College/University

Judy Chiao

John Womelsdorf

Anthony Marucci

John Womelsdorf

Emer Leahy

Undergraduate Degree

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Stanford University College/University

Dan Spiegelman

Ronald Berenson

Undergraduate Degree

Undergraduate Degree

College/University

Christopher Henney

Margaret Helms

Corporate Officer/Principal

Masters Business Admin

AFFYMAX, INC. Biotechnology

Dan Spiegelman

Karin Walker

Director/Board Member

Comptroller/Controller/Auditor

University of Medicine & Dentistry of New Jersey College/University

Sol Barer

Stuart Peltz

Andrew Pecora

Amartya Basu

Chairman

Corporate Officer/Principal

Corporate Officer/Principal

Doctorate Degree

University of Cambridge College/University

John Banham

Robert Jackson

Undergraduate Degree

Undergraduate Degree

Pharmaceuticals: Major

Judy Chiao

Nicholas Bacopoulos

Corporate Officer/Principal

Chief Executive Officer

Rutgers State University of New Jersey College/University

Sol Barer

Michele Korfin

Doctorate Degree

Undergraduate Degree

The Johns Hopkins University College/University

Gregory Reyes

Christopher Henney

Doctorate Degree

Corporate Officer/Principal

Stevens Institute of Technology College/University

John Womelsdorf

John Womelsdorf

Undergraduate Degree

Undergraduate Degree

Yale University College/University

Ronald Berenson

Robert Spiegel

Annarie Lyles

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Medical/Nursing Services

John Gordon McVie

Andrew Pecora

Corporate Officer/Principal

Corporate Officer/Principal

Hospital/Nursing Management

Robert Spiegel

Samuel Barker

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Robert Nelsen

Christopher Henney

Ronald Berenson

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Medical Specialties

Gregory Reyes

Robert Spiegel

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Investment Managers

Robert Nelsen

Kenneth Ferguson

Private Equity Investor

Private Equity Investor

Services to the Health Industry

Christopher Schaber

Jayne C. Gershkowitz

Corporate Officer/Principal

Director/Board Member

American Society for Blood & Marrow Transplantation

Christopher Schaber

Andrew Pecora

Corporate Officer/Principal

Director/Board Member

Pharmaceuticals: Major

David C. U'Prichard

Pierre Legault

Director/Board Member

Director/Board Member

PROTHENA CORPORATION PLC Biotechnology

Christopher Henney

Karin Walker

Director/Board Member

Comptroller/Controller/Auditor

Harvard Business School College/University

Pierre Legault

Michele Korfin

Masters Business Admin

Masters Business Admin

ARMO BIOSCIENCES INC Pharmaceuticals: Major

Pierre Legault

Director/Board Member

Investment Managers

Sol Barer

Robert Spiegel

Consultant / Advisor

Consultant / Advisor

ARIX BIOSCIENCE PLC Investment Managers

David C. U'Prichard

John Banham

Director/Board Member

Director/Board Member

Stone Sunny Isles, Inc.

Pierre Legault

Chief Executive Officer

UROVANT SCIENCES LTD. Pharmaceuticals: Major

Pierre Legault

Director/Board Member

Miscellaneous Commercial Services

Robert Nelsen

Dan Spiegelman

Director/Board Member

Director/Board Member

Statistics

International

United States 45
United Kingdom 3
France 2
Ireland 2
Israel 2

Sectoral

Health Technology 26
Consumer Services 11
Finance 6
Commercial Services 5
Health Services 4

Operational

Director/Board Member 316
Corporate Officer/Principal 111
Independent Dir/Board Member 94
Chairman 72
President 48